カテゴリー： Market Monitor Global, 世界, 医療/バイオ

低分子医薬品有効成分（API）の世界市場見通し2023年-2029年

◆英語タイトル：Small Molecule Active Pharmaceutical Ingredient Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8667 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：128 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Small Molecule Active Pharmaceutical Ingredient Market 調査レポートは次の情報を含め、グローバルにおけるの低分子医薬品有効成分（API）市場規模と予測を収録しています。・世界の低分子医薬品有効成分（API）市場：売上、2018年-2023年、2024年-2029年
・世界の低分子医薬品有効成分（API）市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の低分子医薬品有効成分（API）市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「標準原薬」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

低分子医薬品有効成分（API）のグローバル主要企業は、Johnson Matthey、 Siegfried Holding AG、 Pfizer、 Sanofi S.A.、 Novartis AG,、 Bristol-Myers Squibb、 Boehringer Ingelheim GmbH、 GlaxoSmithKline、 Albany Molecular Research Inc.、 Bachem Holding AG、 PCAS、 Patheon N.V.、 AstraZeneca、 Johnson & Johnson、 Merck & Co、 BASF SE、 Catalent Inc.、 Teva Pharmaceuticals、 Roche、 Cambrex Corporation、 GILEAD Science Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、低分子医薬品有効成分（API）のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の低分子医薬品有効成分（API）市場：タイプ別、2018年-2023年、2024年-2029年
世界の低分子医薬品有効成分（API）市場：タイプ別市場シェア、2022年
・標準原薬、高効能原薬

世界の低分子医薬品有効成分（API）市場：用途別、2018年-2023年、2024年-2029年
世界の低分子医薬品有効成分（API）市場：用途別市場シェア、2022年
・心血管疾患、呼吸器疾患、感染症、その他

世界の低分子医薬品有効成分（API）市場：地域・国別、2018年-2023年、2024年-2029年
世界の低分子医薬品有効成分（API）市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における低分子医薬品有効成分（API）のグローバル売上、2018年-2023年
・主要企業における低分子医薬品有効成分（API）のグローバル売上シェア、2022年
・主要企業における低分子医薬品有効成分（API）のグローバル販売量、2018年-2023年
・主要企業における低分子医薬品有効成分（API）のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Johnson Matthey、 Siegfried Holding AG、 Pfizer、 Sanofi S.A.、 Novartis AG,、 Bristol-Myers Squibb、 Boehringer Ingelheim GmbH、 GlaxoSmithKline、 Albany Molecular Research Inc.、 Bachem Holding AG、 PCAS、 Patheon N.V.、 AstraZeneca、 Johnson & Johnson、 Merck & Co、 BASF SE、 Catalent Inc.、 Teva Pharmaceuticals、 Roche、 Cambrex Corporation、 GILEAD Science Inc.

*************************************************************

・調査・分析レポートの概要
低分子医薬品有効成分（API）市場の定義
市場セグメント
世界の低分子医薬品有効成分（API）市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の低分子医薬品有効成分（API）市場規模
世界の低分子医薬品有効成分（API）市場規模：2022年 VS 2029年
世界の低分子医薬品有効成分（API）市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの低分子医薬品有効成分（API）の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の低分子医薬品有効成分（API）製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：標準原薬、高効能原薬
低分子医薬品有効成分（API）のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：心血管疾患、呼吸器疾患、感染症、その他
低分子医薬品有効成分（API）の用途別グローバル売上・予測

・地域別市場分析
地域別低分子医薬品有効成分（API）市場規模 2022年と2029年
地域別低分子医薬品有効成分（API）売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Johnson Matthey、 Siegfried Holding AG、 Pfizer、 Sanofi S.A.、 Novartis AG,、 Bristol-Myers Squibb、 Boehringer Ingelheim GmbH、 GlaxoSmithKline、 Albany Molecular Research Inc.、 Bachem Holding AG、 PCAS、 Patheon N.V.、 AstraZeneca、 Johnson & Johnson、 Merck & Co、 BASF SE、 Catalent Inc.、 Teva Pharmaceuticals、 Roche、 Cambrex Corporation、 GILEAD Science Inc.
...

This report aims to provide a comprehensive presentation of the global market for Small Molecule Active Pharmaceutical Ingredient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Active Pharmaceutical Ingredient. This report contains market size and forecasts of Small Molecule Active Pharmaceutical Ingredient in global, including the following market information:
Global Small Molecule Active Pharmaceutical Ingredient Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Small Molecule Active Pharmaceutical Ingredient Market Sales, 2018-2023, 2024-2029, (MT)
Global top five Small Molecule Active Pharmaceutical Ingredient companies in 2022 (%)
The global Small Molecule Active Pharmaceutical Ingredient market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Standard API Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Small Molecule Active Pharmaceutical Ingredient include Johnson Matthey, Siegfried Holding AG, Pfizer, Sanofi S.A., Novartis AG,, Bristol-Myers Squibb, Boehringer Ingelheim GmbH, GlaxoSmithKline and Albany Molecular Research Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Small Molecule Active Pharmaceutical Ingredient manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Small Molecule Active Pharmaceutical Ingredient Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Small Molecule Active Pharmaceutical Ingredient Market Segment Percentages, by Type, 2022 (%)
Standard API
High Potency API
Global Small Molecule Active Pharmaceutical Ingredient Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Small Molecule Active Pharmaceutical Ingredient Market Segment Percentages, by Application, 2022 (%)
Cardiovascular Diseases
Respiratory Disorders
Infectious Diseases
Others
Global Small Molecule Active Pharmaceutical Ingredient Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Small Molecule Active Pharmaceutical Ingredient Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Molecule Active Pharmaceutical Ingredient revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Small Molecule Active Pharmaceutical Ingredient revenues share in global market, 2022 (%)
Key companies Small Molecule Active Pharmaceutical Ingredient sales in global market, 2018-2023 (Estimated), (MT)
Key companies Small Molecule Active Pharmaceutical Ingredient sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson Matthey
Siegfried Holding AG
Pfizer
Sanofi S.A.
Novartis AG,
Bristol-Myers Squibb
Boehringer Ingelheim GmbH
GlaxoSmithKline
Albany Molecular Research Inc.
Bachem Holding AG
PCAS
Patheon N.V.
AstraZeneca
Johnson & Johnson
Merck & Co
BASF SE
Catalent Inc.
Teva Pharmaceuticals
Roche
Cambrex Corporation
GILEAD Science Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Small Molecule Active Pharmaceutical Ingredient, market overview.
Chapter 2: Global Small Molecule Active Pharmaceutical Ingredient market size in revenue and volume.
Chapter 3: Detailed analysis of Small Molecule Active Pharmaceutical Ingredient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Small Molecule Active Pharmaceutical Ingredient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Small Molecule Active Pharmaceutical Ingredient capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Small Molecule Active Pharmaceutical Ingredient Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Molecule Active Pharmaceutical Ingredient Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Molecule Active Pharmaceutical Ingredient Overall Market Size
2.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size: 2022 VS 2029
2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Small Molecule Active Pharmaceutical Ingredient Sales: 2018-2029
3 Company Landscape
3.1 Top Small Molecule Active Pharmaceutical Ingredient Players in Global Market
3.2 Top Global Small Molecule Active Pharmaceutical Ingredient Companies Ranked by Revenue
3.3 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Companies
3.4 Global Small Molecule Active Pharmaceutical Ingredient Sales by Companies
3.5 Global Small Molecule Active Pharmaceutical Ingredient Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Small Molecule Active Pharmaceutical Ingredient Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
3.8 Tier 1, Tier 2 and Tier 3 Small Molecule Active Pharmaceutical Ingredient Players in Global Market
3.8.1 List of Global Tier 1 Small Molecule Active Pharmaceutical Ingredient Companies
3.8.2 List of Global Tier 2 and Tier 3 Small Molecule Active Pharmaceutical Ingredient Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Small Molecule Active Pharmaceutical Ingredient Market Size Markets, 2022 & 2029
4.1.2 Standard API
4.1.3 High Potency API
4.2 By Type – Global Small Molecule Active Pharmaceutical Ingredient Revenue & Forecasts
4.2.1 By Type – Global Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2023
4.2.2 By Type – Global Small Molecule Active Pharmaceutical Ingredient Revenue, 2024-2029
4.2.3 By Type – Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
4.3 By Type – Global Small Molecule Active Pharmaceutical Ingredient Sales & Forecasts
4.3.1 By Type – Global Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2023
4.3.2 By Type – Global Small Molecule Active Pharmaceutical Ingredient Sales, 2024-2029
4.3.3 By Type – Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
4.4 By Type – Global Small Molecule Active Pharmaceutical Ingredient Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Small Molecule Active Pharmaceutical Ingredient Market Size, 2022 & 2029
5.1.2 Cardiovascular Diseases
5.1.3 Respiratory Disorders
5.1.4 Infectious Diseases
5.1.5 Others
5.2 By Application – Global Small Molecule Active Pharmaceutical Ingredient Revenue & Forecasts
5.2.1 By Application – Global Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2023
5.2.2 By Application – Global Small Molecule Active Pharmaceutical Ingredient Revenue, 2024-2029
5.2.3 By Application – Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
5.3 By Application – Global Small Molecule Active Pharmaceutical Ingredient Sales & Forecasts
5.3.1 By Application – Global Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2023
5.3.2 By Application – Global Small Molecule Active Pharmaceutical Ingredient Sales, 2024-2029
5.3.3 By Application – Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
5.4 By Application – Global Small Molecule Active Pharmaceutical Ingredient Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Small Molecule Active Pharmaceutical Ingredient Market Size, 2022 & 2029
6.2 By Region – Global Small Molecule Active Pharmaceutical Ingredient Revenue & Forecasts
6.2.1 By Region – Global Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2023
6.2.2 By Region – Global Small Molecule Active Pharmaceutical Ingredient Revenue, 2024-2029
6.2.3 By Region – Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
6.3 By Region – Global Small Molecule Active Pharmaceutical Ingredient Sales & Forecasts
6.3.1 By Region – Global Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2023
6.3.2 By Region – Global Small Molecule Active Pharmaceutical Ingredient Sales, 2024-2029
6.3.3 By Region – Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2029
6.4.2 By Country – North America Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2029
6.4.3 US Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.4.4 Canada Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.4.5 Mexico Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2029
6.5.2 By Country – Europe Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2029
6.5.3 Germany Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.5.4 France Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.5.5 U.K. Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.5.6 Italy Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.5.7 Russia Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.5.8 Nordic Countries Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.5.9 Benelux Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2029
6.6.2 By Region – Asia Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2029
6.6.3 China Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.6.4 Japan Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.6.5 South Korea Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.6.6 Southeast Asia Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.6.7 India Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2029
6.7.2 By Country – South America Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2029
6.7.3 Brazil Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.7.4 Argentina Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales, 2018-2029
6.8.3 Turkey Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.8.4 Israel Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.8.5 Saudi Arabia Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
6.8.6 UAE Small Molecule Active Pharmaceutical Ingredient Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson Matthey
7.1.1 Johnson Matthey Company Summary
7.1.2 Johnson Matthey Business Overview
7.1.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.1.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.1.5 Johnson Matthey Key News & Latest Developments
7.2 Siegfried Holding AG
7.2.1 Siegfried Holding AG Company Summary
7.2.2 Siegfried Holding AG Business Overview
7.2.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.2.4 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.2.5 Siegfried Holding AG Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.3.4 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Sanofi S.A.
7.4.1 Sanofi S.A. Company Summary
7.4.2 Sanofi S.A. Business Overview
7.4.3 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.4.4 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi S.A. Key News & Latest Developments
7.5 Novartis AG,
7.5.1 Novartis AG, Company Summary
7.5.2 Novartis AG, Business Overview
7.5.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.5.4 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.5.5 Novartis AG, Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.6.4 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Boehringer Ingelheim GmbH
7.7.1 Boehringer Ingelheim GmbH Company Summary
7.7.2 Boehringer Ingelheim GmbH Business Overview
7.7.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.7.4 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.7.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.8.4 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 Albany Molecular Research Inc.
7.9.1 Albany Molecular Research Inc. Company Summary
7.9.2 Albany Molecular Research Inc. Business Overview
7.9.3 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.9.4 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.9.5 Albany Molecular Research Inc. Key News & Latest Developments
7.10 Bachem Holding AG
7.10.1 Bachem Holding AG Company Summary
7.10.2 Bachem Holding AG Business Overview
7.10.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.10.4 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.10.5 Bachem Holding AG Key News & Latest Developments
7.11 PCAS
7.11.1 PCAS Company Summary
7.11.2 PCAS Small Molecule Active Pharmaceutical Ingredient Business Overview
7.11.3 PCAS Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.11.4 PCAS Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.11.5 PCAS Key News & Latest Developments
7.12 Patheon N.V.
7.12.1 Patheon N.V. Company Summary
7.12.2 Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Business Overview
7.12.3 Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.12.4 Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.12.5 Patheon N.V. Key News & Latest Developments
7.13 AstraZeneca
7.13.1 AstraZeneca Company Summary
7.13.2 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Business Overview
7.13.3 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.13.4 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.13.5 AstraZeneca Key News & Latest Developments
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Company Summary
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.14.4 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.14.5 Johnson & Johnson Key News & Latest Developments
7.15 Merck & Co
7.15.1 Merck & Co Company Summary
7.15.2 Merck & Co Business Overview
7.15.3 Merck & Co Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.15.4 Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.15.5 Merck & Co Key News & Latest Developments
7.16 BASF SE
7.16.1 BASF SE Company Summary
7.16.2 BASF SE Business Overview
7.16.3 BASF SE Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.16.4 BASF SE Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.16.5 BASF SE Key News & Latest Developments
7.17 Catalent Inc.
7.17.1 Catalent Inc. Company Summary
7.17.2 Catalent Inc. Business Overview
7.17.3 Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.17.4 Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.17.5 Catalent Inc. Key News & Latest Developments
7.18 Teva Pharmaceuticals
7.18.1 Teva Pharmaceuticals Company Summary
7.18.2 Teva Pharmaceuticals Business Overview
7.18.3 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.18.4 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.18.5 Teva Pharmaceuticals Key News & Latest Developments
7.19 Roche
7.19.1 Roche Company Summary
7.19.2 Roche Business Overview
7.19.3 Roche Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.19.4 Roche Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.19.5 Roche Key News & Latest Developments
7.20 Cambrex Corporation
7.20.1 Cambrex Corporation Company Summary
7.20.2 Cambrex Corporation Business Overview
7.20.3 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.20.4 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.20.5 Cambrex Corporation Key News & Latest Developments
7.21 GILEAD Science Inc.
7.21.1 GILEAD Science Inc. Company Summary
7.21.2 GILEAD Science Inc. Business Overview
7.21.3 GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Major Product Offerings
7.21.4 GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023)
7.21.5 GILEAD Science Inc. Key News & Latest Developments
8 Global Small Molecule Active Pharmaceutical Ingredient Production Capacity, Analysis
8.1 Global Small Molecule Active Pharmaceutical Ingredient Production Capacity, 2018-2029
8.2 Small Molecule Active Pharmaceutical Ingredient Production Capacity of Key Manufacturers in Global Market
8.3 Global Small Molecule Active Pharmaceutical Ingredient Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Small Molecule Active Pharmaceutical Ingredient Supply Chain Analysis
10.1 Small Molecule Active Pharmaceutical Ingredient Industry Value Chain
10.2 Small Molecule Active Pharmaceutical Ingredient Upstream Market
10.3 Small Molecule Active Pharmaceutical Ingredient Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Small Molecule Active Pharmaceutical Ingredient Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Small Molecule Active Pharmaceutical Ingredient in Global Market
Table 2. Top Small Molecule Active Pharmaceutical Ingredient Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Companies, 2018-2023
Table 5. Global Small Molecule Active Pharmaceutical Ingredient Sales by Companies, (MT), 2018-2023
Table 6. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Small Molecule Active Pharmaceutical Ingredient Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
Table 9. List of Global Tier 1 Small Molecule Active Pharmaceutical Ingredient Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Small Molecule Active Pharmaceutical Ingredient Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Small Molecule Active Pharmaceutical Ingredient Sales (MT), 2018-2023
Table 15. By Type - Global Small Molecule Active Pharmaceutical Ingredient Sales (MT), 2024-2029
Table 16. By Application – Global Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Small Molecule Active Pharmaceutical Ingredient Sales (MT), 2018-2023
Table 20. By Application - Global Small Molecule Active Pharmaceutical Ingredient Sales (MT), 2024-2029
Table 21. By Region – Global Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Small Molecule Active Pharmaceutical Ingredient Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Small Molecule Active Pharmaceutical Ingredient Sales (MT), 2018-2023
Table 25. By Region - Global Small Molecule Active Pharmaceutical Ingredient Sales (MT), 2024-2029
Table 26. By Country - North America Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Small Molecule Active Pharmaceutical Ingredient Sales, (MT), 2018-2023
Table 29. By Country - North America Small Molecule Active Pharmaceutical Ingredient Sales, (MT), 2024-2029
Table 30. By Country - Europe Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Small Molecule Active Pharmaceutical Ingredient Sales, (MT), 2018-2023
Table 33. By Country - Europe Small Molecule Active Pharmaceutical Ingredient Sales, (MT), 2024-2029
Table 34. By Region - Asia Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Small Molecule Active Pharmaceutical Ingredient Sales, (MT), 2018-2023
Table 37. By Region - Asia Small Molecule Active Pharmaceutical Ingredient Sales, (MT), 2024-2029
Table 38. By Country - South America Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Small Molecule Active Pharmaceutical Ingredient Sales, (MT), 2018-2023
Table 41. By Country - South America Small Molecule Active Pharmaceutical Ingredient Sales, (MT), 2024-2029
Table 42. By Country - Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales, (MT), 2018-2023
Table 45. By Country - Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales, (MT), 2024-2029
Table 46. Johnson Matthey Company Summary
Table 47. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 48. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Johnson Matthey Key News & Latest Developments
Table 50. Siegfried Holding AG Company Summary
Table 51. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 52. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Siegfried Holding AG Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 56. Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Sanofi S.A. Company Summary
Table 59. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 60. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. Sanofi S.A. Key News & Latest Developments
Table 62. Novartis AG, Company Summary
Table 63. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 64. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. Novartis AG, Key News & Latest Developments
Table 66. Bristol-Myers Squibb Company Summary
Table 67. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 68. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. Bristol-Myers Squibb Key News & Latest Developments
Table 70. Boehringer Ingelheim GmbH Company Summary
Table 71. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 72. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 73. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 74. GlaxoSmithKline Company Summary
Table 75. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 76. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 77. GlaxoSmithKline Key News & Latest Developments
Table 78. Albany Molecular Research Inc. Company Summary
Table 79. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 80. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 81. Albany Molecular Research Inc. Key News & Latest Developments
Table 82. Bachem Holding AG Company Summary
Table 83. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 84. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 85. Bachem Holding AG Key News & Latest Developments
Table 86. PCAS Company Summary
Table 87. PCAS Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 88. PCAS Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 89. PCAS Key News & Latest Developments
Table 90. Patheon N.V. Company Summary
Table 91. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 92. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 93. Patheon N.V. Key News & Latest Developments
Table 94. AstraZeneca Company Summary
Table 95. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 96. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 97. AstraZeneca Key News & Latest Developments
Table 98. Johnson & Johnson Company Summary
Table 99. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 100. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 101. Johnson & Johnson Key News & Latest Developments
Table 102. Merck & Co Company Summary
Table 103. Merck & Co Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 104. Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 105. Merck & Co Key News & Latest Developments
Table 106. BASF SE Company Summary
Table 107. BASF SE Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 108. BASF SE Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 109. BASF SE Key News & Latest Developments
Table 110. Catalent Inc. Company Summary
Table 111. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 112. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 113. Catalent Inc. Key News & Latest Developments
Table 114. Teva Pharmaceuticals Company Summary
Table 115. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 116. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 117. Teva Pharmaceuticals Key News & Latest Developments
Table 118. Roche Company Summary
Table 119. Roche Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 120. Roche Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 121. Roche Key News & Latest Developments
Table 122. Cambrex Corporation Company Summary
Table 123. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 124. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 125. Cambrex Corporation Key News & Latest Developments
Table 126. GILEAD Science Inc. Company Summary
Table 127. GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Product Offerings
Table 128. GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 129. GILEAD Science Inc. Key News & Latest Developments
Table 130. Small Molecule Active Pharmaceutical Ingredient Production Capacity (MT) of Key Manufacturers in Global Market, 2021-2023 (MT)
Table 131. Global Small Molecule Active Pharmaceutical Ingredient Capacity Market Share of Key Manufacturers, 2021-2023
Table 132. Global Small Molecule Active Pharmaceutical Ingredient Production by Region, 2018-2023 (MT)
Table 133. Global Small Molecule Active Pharmaceutical Ingredient Production by Region, 2024-2029 (MT)
Table 134. Small Molecule Active Pharmaceutical Ingredient Market Opportunities & Trends in Global Market
Table 135. Small Molecule Active Pharmaceutical Ingredient Market Drivers in Global Market
Table 136. Small Molecule Active Pharmaceutical Ingredient Market Restraints in Global Market
Table 137. Small Molecule Active Pharmaceutical Ingredient Raw Materials
Table 138. Small Molecule Active Pharmaceutical Ingredient Raw Materials Suppliers in Global Market
Table 139. Typical Small Molecule Active Pharmaceutical Ingredient Downstream
Table 140. Small Molecule Active Pharmaceutical Ingredient Downstream Clients in Global Market
Table 141. Small Molecule Active Pharmaceutical Ingredient Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Small Molecule Active Pharmaceutical Ingredient Segment by Type in 2022
Figure 2. Small Molecule Active Pharmaceutical Ingredient Segment by Application in 2022
Figure 3. Global Small Molecule Active Pharmaceutical Ingredient Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Small Molecule Active Pharmaceutical Ingredient Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Small Molecule Active Pharmaceutical Ingredient Revenue, 2018-2029 (US$, Mn)
Figure 7. Small Molecule Active Pharmaceutical Ingredient Sales in Global Market: 2018-2029 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Small Molecule Active Pharmaceutical Ingredient Revenue in 2022
Figure 9. By Type - Global Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 11. By Type - Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 12. By Type - Global Small Molecule Active Pharmaceutical Ingredient Price (USD/MT), 2018-2029
Figure 13. By Application - Global Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 15. By Application - Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 16. By Application - Global Small Molecule Active Pharmaceutical Ingredient Price (USD/MT), 2018-2029
Figure 17. By Region - Global Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 20. By Region - Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 21. By Country - North America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 22. By Country - North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 23. US Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 28. Germany Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 29. France Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Small Molecule Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 37. China Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 41. India Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 43. By Country - South America Small Molecule Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 44. Brazil Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 48. Turkey Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Small Molecule Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 52. Global Small Molecule Active Pharmaceutical Ingredient Production Capacity (MT), 2018-2029
Figure 53. The Percentage of Production Small Molecule Active Pharmaceutical Ingredient by Region, 2022 VS 2029
Figure 54. Small Molecule Active Pharmaceutical Ingredient Industry Value Chain
Figure 55. Marketing Channels

※参考情報

低分子医薬品有効成分（API）は、医薬品の中で主要な治療成分を指す重要な概念です。これらの低分子化合物は通常、生物学的に活性を持ち、特定の疾病の治療に寄与します。ここでは、低分子医薬品有効成分の定義や特徴、種類、用途、関連技術について詳しく説明いたします。

まず、低分子医薬品有効成分の定義についてですが、APIは医薬品の効果を発揮するための主要成分であり、低分子化合物として設計されています。一般に、低分子は分子量が500 Da（ダルトン）以下の化合物で、豊富なバイオ活性を持つため、分子的な設計が行いやすく、新しい治療法の開発においても重要な役割を果たします。低分子は、特に酵素や受容体に対する特異的な結合により生理的な効果をもたらすことができるため、医薬品の開発において広く利用されています。

次に、低分子医薬品の特徴について考えてみましょう。低分子医薬品は、一般に以下のような特徴を持っています。まず、経口投与が可能なため、患者にとって利便性が高いという点です。経口薬は、注射剤に比べて服用が容易で、患者のコンプライアンス向上に寄与します。また、低分子は、細胞膜を透過しやすく、細胞内部での作用が期待できることから、幅広い標的に対して効果を発揮することができます。

さらに、低分子医薬品は製造プロセスにおいても利点があります。合成化学に基づく製造が可能なため、大規模な生産が容易であり、市場での供給が安定しやすいです。また、コスト面でも、生物製剤などに比べて比較的安価に製造できることが多いため、医療経済の観点からも重要な役割を果たしています。

低分子医薬品にはいくつかの種類があります。主なものとしては、抗がん剤、抗菌薬、抗ウイルス薬、抗炎症薬などが挙げられます。抗がん剤は、癌細胞の増殖を抑制することを目指して設計されています。例えば、シスプラチンやタモキシフェンといった化合物は、特定の癌に対して非常に効果を示します。抗菌薬は、細菌感染の治療を目的としており、ペニシリンやセフェム系薬剤などが代表的です。抗ウイルス薬は、ウイルスの複製を阻害することで、感染症の治療に寄与します。抗炎症薬は、炎症を抑える働きを持ち、非ステロイド性抗炎症薬（NSAID）などがあります。

用途においては、低分子医薬品は幅広く利用されています。医療現場では、 chronic disease（慢性疾患）や急性疾患の治療、予防など多岐にわたる用途があります。例えば、糖尿病治療薬や高血圧治療薬は、大多数の患者が日常的に服用する低分子薬に該当します。また、最近では、展開される分子標的治療により、難治性の疾患に対しても低分子医薬品が活用されるようになりました。

関連技術の方に目を向けると、低分子医薬品の開発にはいくつかの先進的な技術が関わっています。ひとつは、構造ベースの薬剤設計（Structure-Based Drug Design, SBDD）です。これは、ターゲットとなるタンパク質の立体構造情報を利用して、より効果的な低分子化合物を設計する手法です。X線結晶解析やNMR（核磁気共鳴）などの技術を用いて、収集した構造情報をもとに、新たな低分子の合成を行います。

さらに、ハイスループットスクリーニング（High-Throughput Screening, HTS）技術も重要です。これは、大量の化合物ライブラリーから対象となる低分子を効率的にスクリーニングする手法で、迅速にリード化合物を特定するのに役立ちます。これにより、新薬候補の発見を加速させ、医薬品開発のサイクルを短縮することができます。

また、現在では計算化学や機械学習を用いたドラッグデザインも盛んになっています。これらの技術は、低分子化合物の特性を予測し、候補化合物を効率的に選定することを可能にします。

低分子医薬品有効成分の開発には、多くのメリットがある一方で、いくつかの課題も存在します。例えば、副作用や耐性の問題です。低分子薬の効果の副作用により、患者に悪影響を及ぼすことがあるため、これを最小限に抑える工夫が求められています。また、耐性菌の増加が懸念されており、特に抗菌薬に関連する問題として広く議論されています。このような課題に対処するため、研究者は新たな分子の探索や、既存の薬剤に対する改良を試みています。

今後の展望としては、低分子医薬品の領域はますます進化していくことが予想されます。対象となる疾患の多様化や新たな治療法の開発が進むことで、多くの患者に対するより効果的な治療が可能になるでしょう。さらに、個別化医療の進展により、患者個々の遺伝的背景や病状に応じた低分子医薬品の開発が行われることで、より精密な治療が実現することが期待されます。

このように、低分子医薬品有効成分は、医薬品開発の中心に位置しており、その役割はますます重要性を増しています。治療の選択肢の拡大や新たな治療法の開発を通じて、これからも多くの患者に希望を与える存在であり続けることでしょう。全体として、低分子医薬品は、今後の医療の進展において欠かすことのできない要素であり、その発展に期待が寄せられています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 低分子医薬品有効成分（API）の世界市場見通し2023年-2029年(Small Molecule Active Pharmaceutical Ingredient Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

低分子医薬品有効成分（API）の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp